Zomedica Corp (ZOM)
0.1395
+0.01
(+4.89%)
USD |
NYAM |
Apr 29, 16:00
0.1399
0.00 (0.00%)
Pre-Market: 08:54
Zomedica Revenue (Quarterly): 7.337M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.337M |
| September 30, 2023 | 6.347M |
| June 30, 2023 | 6.02M |
| March 31, 2023 | 5.482M |
| December 31, 2022 | 6.157M |
| September 30, 2022 | 4.776M |
| Date | Value |
|---|---|
| June 30, 2022 | 4.246M |
| March 31, 2022 | 3.751M |
| December 31, 2021 | 4.081M |
| September 30, 2021 | 0.023M |
| June 30, 2021 | 0.016M |
| March 31, 2021 | 0.014M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.014M
Minimum
Mar 2021
7.337M
Maximum
Dec 2023
4.021M
Average
4.511M
Median
Revenue (Quarterly) Benchmarks
| Ainos Inc | 0.0199M |
| OpGen Inc | 0.699M |
| LENSAR Inc | 12.10M |
| Eargo Inc (DELISTED) | 8.27M |
| Intelligent Bio Solutions Inc | 0.7641M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.41M |
| Total Expenses (Quarterly) | 18.73M |
| EPS Diluted (Quarterly) | -0.023 |
| Enterprise Value | 46.21M |
| Gross Profit Margin (Quarterly) | 69.14% |
| Profit Margin (Quarterly) | -305.4% |
| Earnings Yield | -25.81% |
| Normalized Earnings Yield | -19.09 |